The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus

Prediction of Creatinine Clearance from Serum Creatinine

1976 • 15,066 citations

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

1998 • 5,217 citations

Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents

2005 • 3,153 citations

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

2004 • 2,227 citations

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).

1988 • 2,128 citations

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

1994 • 1,697 citations

Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents

2005 • 673 citations

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American …

2001 • 650 citations

Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”

2003 • 564 citations

Influence of Diabetes Mellitus on Early and Late Outcome After Percutaneous Transluminal Coronary Angioplasty

1995 • 547 citations

Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients

2005 • 498 citations

Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials

2002 • 426 citations

Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients

2004 • 403 citations

Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients

2005 • 373 citations

Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients

2001 • 342 citations

Potential mechanisms promoting restenosis in diabetic patients

1996 • 329 citations

Stent Thrombosis Is Associated With an Impaired Response to Antiplatelet Therapy

2005 • 285 citations

Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus

2005 • 256 citations

mTOR Signaling to Translation

2004 • 255 citations

The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population

2005 • 230 citations

Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study

2001 • 226 citations

Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients

2004 • 186 citations

Cardiovascular Risk Assessment Based on US Cohort Studies

2001 • 159 citations

Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients Insights from the RAVEL Trial

2004 • 120 citations

Importance of Considering Atherosclerosis Progression When Choosing a Coronary Revascularization Strategy

1999 • 97 citations

Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials

2005 • 83 citations

Sirolimus-Eluting Stents Remain Superior to Bare-Metal Stents at Two Years

2006 • 81 citations

Important Triad in Cardiovascular Medicine

2003 • 68 citations

Comparison of Short- (One Month) and Long- (Twelve Months) Term Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents in 293 Consecutive Patients With Diabetes Mellitus (from the RESEARCH and T-SEARCH Registries)

2005 • 64 citations

Three-Year Clinical Follow-Up of the Unrestricted Use of Sirolimus-Eluting Stents as Part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry

2006 • 64 citations

Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients.

1997 • 62 citations

Long-term clopidogrel therapy after percutaneous coronary intervention in PCI-CURE and CREDO: the “Emperor's New Clothes” revisited

2004 • 53 citations

TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?

2004 • 42 citations

Impact of Diabetes Mellitus on Angiographic and Clinical Outcomes in the Drug-Eluting Stents Era

2005 • 42 citations

Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments.

2006 • 17 citations